IPP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.805200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.984400E-01
Normal-vs-Stage2
6.597600E-01
Normal-vs-Stage3
1.559580E-01
Normal-vs-Stage4
3.710000E-01
Stage1-vs-Stage2
2.940600E-01
Stage1-vs-Stage3
2.471800E-02
Stage1-vs-Stage4
3.837800E-01
Stage2-vs-Stage3
7.5280000000344E-07
Stage2-vs-Stage4
3.341900E-02
Stage3-vs-Stage4
5.164400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.565400E-01
Normal-vs-AfricanAmerican
9.356400E-01
Normal-vs-Asian
5.305600E-01
Caucasian-vs-AfricanAmerican
4.449000E-01
Caucasian-vs-Asian
4.851200E-01
AfricanAmerican-vs-Asian
3.691200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.270600E-01
Normal-vs-Female
8.388800E-01
Male-vs-Female
2.052800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.342800E-01
Normal-vs-Age(41-60Yrs)
9.864000E-01
Normal-vs-Age(61-80Yrs)
5.269400E-01
Normal-vs-Age(81-100Yrs)
4.792200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.991200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.178200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.307200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.874300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.695830E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.110800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.231800E-01
Normal-vs-Daily Drinker
2.931600E-01
Normal-vs-Weekly Drinker
2.889400E-01
Normal-vs-Occasional Drinker
8.773800E-01
Normal-vs-Social Drinker
9.375200E-01
Non Drinker-vs-Daily Drinker
4.717800E-01
Non Drinker-vs-Weekly Drinker
5.512600E-01
Non Drinker-vs-Occasional Drinker
1.182390E-01
Non Drinker-vs-Social Drinker
1.922240E-01
Daily Drinker-vs-Weekly Drinker
9.717600E-01
Daily Drinker-vs-Occasional Drinker
3.240000E-02
Daily Drinker-vs-Social Drinker
6.498500E-02
Weekly Drinker-vs-Occasional Drinker
5.953500E-02
Weekly Drinker-vs-Social Drinker
1.044040E-01
Occasional Drinker-vs-Social Drinker
9.070600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.308030E-01
Normal-vs-Grade 2
4.472200E-02
Normal-vs-Grade 3
1.597620E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.359400E-01
Grade 1-vs-Grade 3
1.477840E-01
Grade 1-vs-Grade 4
1.308030E-01
Grade 2-vs-Grade 3
3.234400E-01
Grade 2-vs-Grade 4
4.472200E-02
Grade 3-vs-Grade 4
1.597620E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.502400E-01
Normal-vs-NonDiabetic
5.727600E-01
Diabetic-vs-NonDiabetic
6.388200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.587800E-01
Normal-vs-NoPancreatitis
5.930800E-01
Pancreatitis-vs-NoPancreatitis
8.798600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.905600E-01
Normal-vs-N1
6.962800E-01
N0-vs-N1
9.091000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.738600E-01
Normal-vs-TP53-NonMutant
9.462200E-01
TP53-Mutant-vs-TP53-NonMutant
8.993600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
